MENU
+Compare
MDXG
Stock ticker: NASDAQ
AS OF
May 14 closing price
Price
$6.96
Change
-$0.21 (-2.93%)
Capitalization
1.03B

MDXG MiMedx Group Forecast, Technical & Fundamental Analysis

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more

Industry: #Biotechnology
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MDXG with price predictions
May 13, 2025

MDXG's RSI Indicator recovers from oversold territory

The RSI Indicator for MDXG moved out of oversold territory on May 05, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 07, 2025. You may want to consider a long position or call options on MDXG as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MDXG just turned positive on April 24, 2025. Looking at past instances where MDXG's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MDXG advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

MDXG moved below its 50-day moving average on May 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for MDXG moved below the 200-day moving average on April 30, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MDXG broke above its upper Bollinger Band on May 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MDXG entered a downward trend on May 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.068) is normal, around the industry mean (14.420). P/E Ratio (25.778) is within average values for comparable stocks, (65.047). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.146). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.942) is also within normal values, averaging (254.920).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

View a ticker or compare two or three
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MDXG is expected to report earnings to rise 3.33% to 6 cents per share on August 05

MiMedx Group MDXG Stock Earnings Reports
Q2'25
Est.
$0.06
Q1'25
Est.
$0.06
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Est.
$0.08
The last earnings report on April 30 showed earnings per share of 5 cents, meeting the estimate of 5 cents. With 648.51K shares outstanding, the current market capitalization sits at 1.03B.
A.I. Advisor
published General Information

General Information

a manufacturer of patent protected regenerative biomaterial products and bioimplants

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGIEX19.90N/A
N/A
Franklin International Equity I
HGHRX32.69N/A
N/A
Hartford Healthcare R3
OTCBX21.97N/A
N/A
MFS Mid Cap Growth B
LMPSX34.05N/A
N/A
ClearBridge Small Cap Growth FI
CAPOX10.78N/A
N/A
Absolute Capital Opportunities Instl

MDXG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-2.93%
AXON - MDXG
47%
Loosely correlated
+0.52%
VCYT - MDXG
42%
Loosely correlated
-2.80%
ARRY - MDXG
39%
Loosely correlated
+0.73%
RAPT - MDXG
38%
Loosely correlated
+0.31%
INM - MDXG
38%
Loosely correlated
+28.24%
More